COPD/Asthma Clinic

Director: Shaylee Peckens, MD

The prevalence of chronic obstructive pulmonary disease (COPD) in West Virginia is 8%, the 4th highest in the nation.[1] Approximately 13.7% of West Virginia adults have ever been diagnosed with asthma, and 9.6% of West Virginia adults currently had asthma.[2] West Virginia is presently ranked 50th as a state in smoking rates with nearly 27.4% of the population as current smokers.[3] Nationally, COPD accounted for $50 Billion in total costs in 2010.[4]

The COPD/Asthma Clinic was created in the spring of 2015. The inter-professional team includes a faculty physician, pharmacist, dietician/smoking cessation counselor, respiratory therapist (when available), medical students, and pharmacy students at all levels. It is offered once weekly on Friday afternoons.

COPD clinic variables include a COPD Assessment Test (to evaluate the severity of symptoms), Nicotine Dependence Survey, and in-office spirometry when needed. The team works effectively to care for all aspects of COPD: assessing patient goals and barriers, medication adherence and affordability, and smoking cessation.

For more information, please contact Shaylee Peckens, MD

A photo of Shaylee Peckens.

Shaylee Peckens, MD

West Virginia University
Assistant Professor, Director of Department Quality, Family Medicine

[1] Centers for Disease Control and Prevention (CDC). (2012, November 23). Chronic obstructive pulmonary disease among adults – United States, 2011. MMWR. Morbidity and Mortality Weekly Report. Retrieved from

[2] Centers for Disease Control and Prevention (CDC). (2008). Asthma in West Virginia. National Centers for Environmental Health Division of Environmental Hazards and Health Effects. Retrieved from

[3] Centers for Disease Control and Prevention (CDC). (2015). Current smoking among adults aged >= 18 years – United States – age-adjusted prevalence. Leading indicators for chronic disease risk factors. Retrieved from

[4] Guarascio AJ, Ray SM, Finch CK, Self TH. (2013, Jun 17). The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013 Jun 17;5:235-45. doi: 10.2147/CEOR.S34321. Print 2013.